Besponsa

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0008-0100
  • Package NDC 0008-0100-01
  • Application number BLA761040
  • SPL ID 427d10d2-c29d-4b71-a5fe-c97736d59aa6
  • SPL set ID cc7014b1-c775-411d-b374-8113248b4077
  • UNII P93RUU11P7
  • RxCUI 1942954
  • RxCUI 1942959

What the source publishes

Labeler
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Active ingredients
inotuzumab ozogamicin
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0008-0100_427d10d2-c29d-4b71-a5fe-c97736d59aa6
{
  "name": "Besponsa",
  "splId": "427d10d2-c29d-4b71-a5fe-c97736d59aa6",
  "labels": [
    {
      "setId": "cc7014b1-c775-411d-b374-8113248b4077",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc7014b1-c775-411d-b374-8113248b4077",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cc7014b1-c775-411d-b374-8113248b4077"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0008-0100-01)  / 4 mL in 1 VIAL, SINGLE-DOSE",
      "package_ndc": "0008-0100-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20170818"
    }
  ],
  "productId": "0008-0100_427d10d2-c29d-4b71-a5fe-c97736d59aa6",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "productNdc": "0008-0100",
  "deaSchedule": null,
  "genericName": "inotuzumab ozogamicin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "INOTUZUMAB OZOGAMICIN",
      "strength": ".25 mg/mL"
    }
  ],
  "applicationNumber": "BLA761040",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20170818",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000193617",
      "N0000193616",
      "N0000008576",
      "N0000009176",
      "M0028142"
    ],
    "unii": [
      "P93RUU11P7"
    ],
    "rxcui": [
      "1942954",
      "1942959"
    ],
    "spl_set_id": [
      "cc7014b1-c775-411d-b374-8113248b4077"
    ],
    "pharm_class_cs": [
      "Immunoconjugates [CS]"
    ],
    "pharm_class_pe": [
      "Decreased DNA Integrity [PE]",
      "Increased Cellular Death [PE]"
    ],
    "pharm_class_epc": [
      "CD22-directed Immunoconjugate [EPC]"
    ],
    "pharm_class_moa": [
      "CD22-directed Antibody Interactions [MoA]"
    ],
    "manufacturer_name": [
      "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0008-0100_427d10d2-c29d-4b71-a5fe-c97736d59aa6"